Official Title
COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients
Brief Summary

The aims of this study is to define the genetic bases of COVID-19 related disease heterogeneity in frail population, to carry out a retrospective study on individuals w/wo symptoms to verify the reliability of a prognostic/diagnostic test based on IgM/IgG analysis and on the presence of genetic profiling and to explore the therapeutic potential of the modulation of ACE2 expression.

Status
Unknown status
Conditions
COVID-19
Interventions

Other: BioMedomics COVID-19 IgM-IgG Rapid Test

Qualitative test to aid in the diagnosis of COVID-19 novel coronavirus

Eligibility Criteria

Inclusion Criteria:

- adult patients (> 18 years old)

Exclusion Criteria:

- inability to understand and want;

- mentally incapacitated.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Italy
Locations

AO San Paolo
Milan, IT, Italy

Investigator: Stefano Centanni, Full Professor
Contact: 0281843025
stefano.centanni@unimi.it

Contacts

Stefano Centanni, Full Professor
0281843025
stefano.centanni@unimi.it

Sponsors / Collaborators
Azienda Ospedaliera San Paolo
NCT Number
NCT04367402
MeSH Terms
COVID-19